Overit Turkey
KAP membership endedNOBELA.Ş.
Nobel İlaç Sanayii ve Ticaret A.Ş.

Nobel İlaç Sanayii ve Ticaret A.Ş.

Registered seat: İstanbul

Identifiers

BIST ticker
NOBEL
Tax number
6310070138
Auditor
Eren Bağımsız Denetim A.Ş.

Financial statements

Consolidated and standalone statements are shown separately and are never compared with one another.

Revenue₺1.02bn+28.9% Change
2016201720182019
Net profit / loss₺154m+20.9% Change
2016201720182019
Total assets₺1.37bn+30.8% Change
2016201720182019
Equity₺445m+51.6% Change
2016201720182019
Year2019December 31, 20192018*December 31, 20182017December 31, 20172016*December 31, 2016
Revenue₺1.02bn₺791m₺587m₺449m
Gross profit₺633m₺493m₺368m₺283m
Operating profit₺259m₺270m₺135m₺121m
EBITDA₺277m₺284m₺146m₺131m
Profit before tax₺171m₺150m₺80.1m₺53.3m
Net profit / loss₺154m₺128m₺61.8m₺47.9m
Cash and cash equivalents₺46.7m₺22.2m₺37.6m₺11.7m
Current assets₺850m₺623m₺468m₺333m
Non-current assets₺516m₺422m₺326m₺282m
Total assets₺1.37bn₺1.05bn₺794m₺615m
Equity₺445m₺294m₺177m₺117m
Current liabilities₺514m₺386m₺334m₺250m
Non-current liabilities₺408m₺365m₺283m₺248m
Total liabilities₺921m₺751m₺617m₺498m
Cash flow from operating activities₺-5.54m₺18.3m₺32.5m₺-58.7m

* Read from a later filing's comparative column. Reporting standard: TFRS. Presentation unit: TL.

Disclosures

Sources

  • Public Disclosure Platform (KAP)

The information on this page comes from the official sources below. Overit is not affiliated with them.